Press release
Nebulizers to be Fastest Growing Segment of Global Pulmonary Drug Delivery Systems Market
Download Exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=873
The high permeability and large absorptive surface area of lungs, along with steady blood supply, leads to faster absorption of drugs into the bloodstream. Increased adoption of pulmonary drug delivery is expected to push the global pulmonary drug delivery systems market during the period between 2013 and 2019.
According to the World Health Organization, around 300 million people across the globe suffer from asthma. Growing patient pool affected with respiratory diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD) is one of the prime factors set to contribute to the global pulmonary drug delivery systems market.
Rapid absorption of different macromolecules and most of the therapeutic drugs over the alveolar epithelium of the distal lung has allowed pulmonary drug delivery systems to become efficacious. Technical advances in pulmonary drug delivery systems as well as drug formulations are expected to propel the overall market in the near future. Presently, the therapeutic applications of pulmonary drug delivery are expanding and this will help the market’s growth prospects.
However, patent expiry of drug delivery systems and delay in obtaining approvals from regulatory authorities are expected to negatively affect the global pulmonary drug delivery systems market. During the next couple of years, developing economies will present immense market potential for pulmonary drug delivery systems, owing to the growing patient base.
On the basis of product type, the global pulmonary drug delivery systems market has been segmented into nebulizers, metered dose inhalers (MDIs), and dry powder inhalers (DPIs). In 2012, the overall market was dominated by metered dose inhalers, which accounted for 56.8% of the market. Dry powder inhalers were the second largest segment in the market the same year.
During the period between 2013 and 2019, nebulizers are expected to be the fastest growing segment of the pulmonary drug delivery systems market. In terms of application, the global pulmonary drug delivery systems market has been categorized into cystic fibrosis, asthma, and chronic obstructive pulmonary disease (COPD). In the coming years, the usage of pulmonary drug delivery systems for the treatment of asthma and COPD is expected to increase considerably.
Globally, the pulmonary drug delivery systems market has been divided into four key regions: Europe, Asia Pacific, North America, and Rest of the World. In 2012, North America was the leading market for pulmonary drug delivery systems, owing to the increasing patient base and robust healthcare infrastructure.
View Full Research Report: http://www.transparencymarketresearch.com/pulmonary-drug-delivery-systems.html
During the period between 2013 and 2019, Asia Pacific is expected to contribute significantly to the growth of the market due to the growing number of people smoking tobacco. Some of the key players in the global pulmonary drug delivery systems market are CareFusion Corporation, 3M Health Care, Novartis AG, Omron Healthcare Inc., and GlaxoSmithKline.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nebulizers to be Fastest Growing Segment of Global Pulmonary Drug Delivery Systems Market here
News-ID: 433590 • Views: …
More Releases from TMR
Emerging Opportunities in Logistics Market with Current Trends Analysis
The global Logistics market is estimated to attain a valuation of US$ 15,273.21 Bn by the end of 2027, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4.5% during the forecast period, 2019-2027.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the…
Energy Measurement IC Market is expected to reach US$ 8.39 Bn by the end of 2031
According to a Transparency Market Research (TMR) research report, the global energy measurement ic market is likely to expand at a CAGR of 7.4% during the forecast period, 2022 to 2031. This suggests that the market is expected to reach US$ 8.39 Bn by the end of 2031.
The study on the energy measurement ic market adopts rigorous and systematic research approaches to understand the growth dynamic of the market. The…
STATCOM UPS Market to Register Double Digit Growth Rate of 16% CAGR by 2024
Over the last decade, rising number of industries and utilities are opting for static synchronous compensator or STATCOM UPS instead of static VAR compensator or SVC UPS. Low harmonic emission coupled with high speed of response is accentuating the expansion of India STATCOM UPS market now and in times to come. Playing a crucial role in voltage control and compensation of reactive power, STATCOM UPS is likely to keep its…
Thin Wafer Processing and Dicing Equipment Market US$692.5 mn by 2024 - TMR
Transparency Market Research (TMR) estimates that the global thin wafer processing and dicing equipment market has a highly consolidative landscape. Disco Corp. accounted for largest share of 56.4% in 2015 and likely to be dominant in the coming years. This is creating monopoly in the thin wafer processing and dicing equipment market in terms of competitive presence. The other key players such as EV Group, Plasma-Therm LLC, Lam Research Corp,…
More Releases for Pulmonary
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers…
Global Pulmonary Embolism Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pulmonary Embolism Market is exhibited at USD 1.59 billion in 2023 and is projected to surpass USD 3.15 billion in 2028, anticipated to grow at a CAGR of 8.4% from 2023 to 2028.
The rapid increase in the prevalence of cancer, increasing investment for healthcare infrastructure and rising research and development activities, high disposable income, rising demand…
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
